Adamis Pharmaceuticals Corp

NASDAQ:ADMP   9:58:50 AM EDT
0.40
-0.01 (-2.49%)
Earnings Announcements

Adamis Pharmaceuticals Reports Full Year 2021 Financial Results And Provides Corporate Update

Published: 03/31/2022 21:35 GMT
Adamis Pharmaceuticals Corp (ADMP) - Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update.
Adamis Pharmaceuticals Corp - Cash and Equivalents As of December 31, 2021, Totaled Approximately $23.2 Million.
Revenue is expected to be $1.84 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $3.99 Million
Next Quarter EPS Guidance is expected to be -$0.03

More details on our Analysts Page.